These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28956034)

  • 61. Diagnostic value of quantitative contrast-enhanced ultrasound (CEUS) for early detection of renal hyperperfusion in diabetic kidney disease.
    Wang L; Wu J; Cheng JF; Liu XY; Ma F; Guo LH; Xu JM; Wu T; Mohan C; Peng A; Xu HX; Song YX
    J Nephrol; 2015 Dec; 28(6):669-78. PubMed ID: 25712236
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study.
    Cid Ruzafa J; Paczkowski R; Boye KS; Di Tanna GL; Sheetz MJ; Donaldson R; Breyer MD; Neasham D; Voelker JR
    Int J Clin Pract; 2015 Aug; 69(8):871-82. PubMed ID: 26011029
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mitochondrial dysfunction in diabetic kidney disease.
    Wei PZ; Szeto CC
    Clin Chim Acta; 2019 Sep; 496():108-116. PubMed ID: 31276635
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Gender differences in the association between HDL cholesterol and the progression of diabetic kidney disease in type 2 diabetic patients.
    Hanai K; Babazono T; Yoshida N; Nyumura I; Toya K; Hayashi T; Bouchi R; Tanaka N; Ishii A; Iwamoto Y
    Nephrol Dial Transplant; 2012 Mar; 27(3):1070-5. PubMed ID: 21785041
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Determinants of visfatin in type 2 diabetes patients with diabetic kidney disease: Relationship to inflammation, adiposity and undercarboxylated osteocalcin.
    Kacso AC; Bondor CI; Coman AL; Potra AR; Georgescu CE
    Scand J Clin Lab Invest; 2016; 76(3):217-25. PubMed ID: 26922969
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gender differences in the association between hyperuricemia and diabetic kidney disease in community elderly patients.
    Guo M; Niu JY; Li SR; Ye XW; Fang H; Zhao YP; Gu Y
    J Diabetes Complications; 2015; 29(8):1042-9. PubMed ID: 26387809
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Glucose- and Non-Glucose-Induced Mitochondrial Dysfunction in Diabetic Kidney Disease.
    Ito M; Gurumani MZ; Merscher S; Fornoni A
    Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327540
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Metabolomics Study of Roux-en-Y Gastric Bypass Surgery (RYGB) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography-Mass Spectrometry.
    Luo P; Yu H; Zhao X; Bao Y; Hong CS; Zhang P; Tu Y; Yin P; Gao P; Wei L; Zhuang Z; Jia W; Xu G
    J Proteome Res; 2016 Apr; 15(4):1288-99. PubMed ID: 26889720
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Biomarkers of diabetic nephropathy: A 2017 update.
    Papadopoulou-Marketou N; Kanaka-Gantenbein C; Marketos N; Chrousos GP; Papassotiriou I
    Crit Rev Clin Lab Sci; 2017 Aug; 54(5):326-342. PubMed ID: 28956668
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The association of ACE gene polymorphism with diabetic kidney disease and renoprotective efficacy of valsartan.
    Wang Y; Peng W; Zhang X; Qiao H; Wang L; Xu Z; Wu C
    J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27638852
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diabetic kidney disease: a report from an ADA Consensus Conference.
    Tuttle KR; Bakris GL; Bilous RW; Chiang JL; de Boer IH; Goldstein-Fuchs J; Hirsch IB; Kalantar-Zadeh K; Narva AS; Navaneethan SD; Neumiller JJ; Patel UD; Ratner RE; Whaley-Connell AT; Molitch ME
    Am J Kidney Dis; 2014 Oct; 64(4):510-33. PubMed ID: 25257325
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy.
    Zhu C; Liang QL; Hu P; Wang YM; Luo GA
    Talanta; 2011 Sep; 85(4):1711-20. PubMed ID: 21872008
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Performance of urinary neutrophil gelatinase-associated lipocalin, clusterin, and cystatin C in predicting diabetic kidney disease and diabetic microalbuminuria: a consecutive cohort study.
    Zeng XF; Lu DX; Li JM; Tan Y; Li Z; Zhou L; Xi ZQ; Zhang SM; Duan W
    BMC Nephrol; 2017 Jul; 18(1):233. PubMed ID: 28701152
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Use of Contrast-Enhanced Ultrasound to Study Relationship between Serum Uric Acid and Renal Microvascular Perfusion in Diabetic Kidney Disease.
    Wang L; Cheng JF; Sun LP; Song YX; Guo LH; Xu JM; Wu TF; Mohan C; Peng A; Xu HX; Liu XY
    Biomed Res Int; 2015; 2015():732317. PubMed ID: 26106613
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Risk Factors for the Development and Progression of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Advanced Diabetic Retinopathy.
    Yun KJ; Kim HJ; Kim MK; Kwon HS; Baek KH; Roh YJ; Song KH
    Diabetes Metab J; 2016 Dec; 40(6):473-481. PubMed ID: 27766790
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial.
    Agha A; Amer W; Anwar E; Bashir K
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):429-35. PubMed ID: 19414946
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mitochondrial dynamics and diabetic kidney disease: Missing pieces for the puzzle of therapeutic approaches.
    Narongkiatikhun P; Chattipakorn SC; Chattipakorn N
    J Cell Mol Med; 2022 Jan; 26(2):249-273. PubMed ID: 34889040
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tissue metabolomic fingerprinting reveals metabolic disorders associated with human gastric cancer morbidity.
    Song H; Wang L; Liu HL; Wu XB; Wang HS; Liu ZH; Li Y; Diao DC; Chen HL; Peng JS
    Oncol Rep; 2011 Aug; 26(2):431-8. PubMed ID: 21567103
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Weight loss interventions and progression of diabetic kidney disease.
    Docherty NG; Canney AL; le Roux CW
    Curr Diab Rep; 2015 Aug; 15(8):55. PubMed ID: 26122095
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Modulation of advanced glycation end products by candesartan in patients with diabetic kidney disease--a dose-response relationship study.
    Saha SA; LaSalle BK; Clifton GD; Short RA; Tuttle KR
    Am J Ther; 2010; 17(6):553-8. PubMed ID: 19829095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.